Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |